The lysis efficiency of the tumor cell lines CD133−SW620 (Figure 6B) and 7721 (Figure 6C) at an E:T ratio of 10:1 was enhanced in the presence of anti-ULBP3 monoclonal antibody (B2-F1-F1). The gene discussed is ULBP3; the disease is neoplasm.